Compare · STE vs WMGI
STE vs WMGI
Side-by-side comparison of STERIS plc (Ireland) (STE) and Wright Medical Group N.V. (WMGI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both STE and WMGI operate in Industrial Specialties (Health Care), so they compete in similar markets.
- STE carries a market cap of $21.99B.
- STE has hit the wire 3 times in the past 4 weeks while WMGI has been quiet.
- STE has more recent analyst coverage (16 ratings vs 0 for WMGI).
- Company
- STERIS plc (Ireland)
- Wright Medical Group N.V.
- Price
- $221.72-0.76%
- -
- Market cap
- $21.99B
- -
- 1M return
- -0.80%
- -
- 1Y return
- -1.52%
- -
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NASDAQ
- IPO
- 2011
- News (4w)
- 3
- 0
- Recent ratings
- 16
- 0
STERIS plc (Ireland)
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. This segment offers its products and services to acute care hospitals and other healthcare settings. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The company is based in Dublin, Ireland.
Latest STE
- STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026
- Teleflex Announces Governance Updates
- SEC Form 8-K filed by STERIS plc (Ireland)
- Amendment: SEC Form SCHEDULE 13G/A filed by STERIS plc (Ireland)
- Director Feldmann Cynthia L exercised 3,098 units of Ordinary Shares at a strike of $152.32 and sold $734,877 worth of Ordinary Shares (3,098 units at $237.21) (SEC Form 4)
- SEC Form 144 filed by STERIS plc (Ireland)
- SEC Form 10-Q filed by STERIS plc (Ireland)
- STERIS plc (Ireland) filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- STERIS Announces Financial Results for Fiscal 2026 Third Quarter
- STERIS Announces Dividend of $0.63 per share
Latest WMGI
- Wright Medical Announces Fundamental Change With Respect to the 2.25% Cash Convertible Senior Notes due 2021 issued by Wright Medical Group N.V. and the 1.625% Cash Exchangeable Senior Notes due 2023 issued by Wright Medical Group, Inc.
- Stryker completes acquisition of Wright Medical
- Stryker announces intention to complete acquisition of Wright Medical
- Stryker announces receipt of all required regulatory approvals for proposed acquisition of Wright Medical
- Stryker extends cash tender offer for all outstanding shares of Wright Medical
- Stryker extends cash tender offer for all outstanding shares of Wright Medical